OPREVENT2: Design of a multi-institutional intervention for obesity control and prevention for American Indian adults.

Joel Gittelsohn, Brittany Jock, Leslie Redmond, Sheila Fleischhacker, Thomas Eckmann, Sara N Bleich, Hong Loh, Elizabeth Ogburn, Preety Gadhoke, Jacqueline Swartz, Marla Pardilla, Benjamin Caballero

Journal: BMC public health 2017;17(1):105

PMID: 28114926

Abstract

BACKGROUND

Obesity and other nutrition-related chronic disease rates are high in American Indian (AI) populations, and an urgent need exists to identify evidence-based strategies for prevention and treatment. Multi-level, multi-component (MLMC) interventions are needed, but there are significant knowledge gaps on how to deliver these types of interventions in low-income rural AI communities.

METHODS

OPREVENT2 is a MLMC intervention targeting AI adults living in six rural reservations in New Mexico and Wisconsin. Aiming to prevent and reduce obesity in adults by working at multiple levels of the food and physical activity (PA) environments, OPREVENT2 focuses on evidence-based strategies known to increase access to, demand for, and consumption of healthier foods and beverages, and increase worksite and home-based opportunities for PA. OPREVENT2 works to create systems-level change by partnering with tribal stakeholders, multiple levels of the food and PA environment (food stores, worksites, schools), and the social environment (children as change agents, families, social media). Extensive evaluation will be conducted at each level of the intervention to assess effectiveness via process and impact measures.

DISCUSSION

Novel aspects of OPREVENT2 include: active engagement with stakeholders at many levels (policy, institutional, and at multiple levels of the food and PA system); use of community-based strategies to engage policymakers and other key stakeholders (community workshops, action committees); emphasis on both the built environment (intervening with retail food sources) and the social environment. This paper describes the design of the intervention and the evaluation plan of the OPREVENT2.

TRIAL REGISTRATION

Clinical Trial Registration: NCT02803853 (June 10, 2016).

Address: Johns Hopkins University, Bloomberg School of Public Health, 615 N. Wolfe St. Suite W2041, Baltimore, MD, 21205, USA. [email protected].; Johns Hopkins University, Bloomberg School of Public Health, 615 N. Wolfe St. Suite W2041, Baltimore, MD, 21205, USA.; National Institute of Diabetes, Digestive and Kidney Diseases Office of Nutrition Research, Bethesda, USA.; Harvard T.H. Chan School of Public Health, Boston, USA.; St. John's University, Queens, NY, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.